Oxidized LDL-Activated Platelets Induce Vascular Inflammation

 

 Buy Article Permissions and Reprints

ABSTRACT

Platelets are involved in the initiation of atherosclerosis by adherence to inflamed endothelium. Monocytes bind to these platelets and transmigrate into the vessel wall, transforming into macrophages and foam cells. We have previously shown that lipid-laden platelets are phagocytosed by macrophages. In this study we investigated the functional consequences of oxidized low-density lipoprotein (oxLDL) uptake on platelet function and interaction with the endothelium. Human platelets were isolated from healthy donors and activated by adenosine diphosphate. Immunofluorescence microscopy and flow cytometry revealed that oxLDL is located intracellularly in vesicles. With mepacrine costaining and confocal microtomography, we were able to identify dense granules as the vesicles that contain oxLDL. OxLDL-laden platelets induced intercellular adhesion molecule 1 expression in endothelial cells more than exogenous native LDL, oxLDL, and oxLDL-negative platelets. Furthermore, oxLDL-laden platelets induced foam cell development from CD34⁺ progenitor cells. On endothelial regeneration, oxLDL-laden platelets had the opposite effect: The number of CD34⁺ progenitor cells (colony-forming units) able to transform into endothelial cells was significantly reduced in the presence of oxLDL-platelets, whereas native LDL had no effect. Our results demonstrate that activated platelets internalize oxLDL and that oxLDL-laden platelets activate endothelium, inhibit endothelial regeneration, and promote foam cell development. Platelet oxLDL contributes significantly to vascular inflammation and is able to promote atherosclerosis.

REFERENCES

• 1 Massberg S, Brand K, Grüner S et al.. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.  J Exp Med. 2002;  196(7) 887-896
  CrossrefPubMedGoogle Scholar
• 2 Ruggeri Z M. Platelets in atherothrombosis.  Nat Med. 2002;  8 1227-1234
  CrossrefPubMedGoogle Scholar
• 3 Gawaz M, Langer H, May A E. Platelets in inflammation and atherogenesis.  J Clin Invest. 2005;  115(12) 3378-3384
  CrossrefPubMedGoogle Scholar
• 4 Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium.  Cardiovasc Res. 2004;  61(3) 498-511
  CrossrefPubMedGoogle Scholar
• 5 Massberg S, Enders G, Leiderer R et al.. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin.  Blood. 1998;  92(2) 507-515
  PubMedGoogle Scholar
• 6 Burger P C, Wagner D D. Platelet P-selectin facilitates atherosclerotic lesion development.  Blood. 2003;  101(7) 2661-2666
  CrossrefPubMedGoogle Scholar
• 7 Siegel-Axel D, Langer H, Lindemann S, Gawaz M. Role of platelets in atherosclerosis and inflammation [in German].  Med Klin (Munich). 2006;  101(6) 467-475
  CrossrefPubMedGoogle Scholar
• 8 Lusis A J. Atherosclerosis.  Nature. 2000;  407(6801) 233-241
  CrossrefPubMedGoogle Scholar
• 9 Daub K, Langer H, Seizer P et al.. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.  FASEB J. 2006;  20 2559-2561
  CrossrefPubMedGoogle Scholar
• 10 Engelmann B, Kögl C, Kulschar R, Schaipp B. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.  Biochem J. 1996;  315(Pt 3) 781-789
  PubMedGoogle Scholar
• 11 Asch A S, Silbiger S, Heimer E, Nachman R L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.  Biochem Biophys Res Commun. 1992;  182(3) 1208-1217
  CrossrefPubMedGoogle Scholar
• 12 Tandon N N, Kralisz U, Jamieson G A. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.  J Biol Chem. 1989;  264(13) 7576-7583
  PubMedGoogle Scholar
• 13 Aiken M L, Ginsberg M H, Byers-Ward V, Plow E F. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression.  Blood. 1990;  76(12) 2501-2509
  PubMedGoogle Scholar
• 14 Marcus A J, Silk S T, Safier L B, Ullman H L. Superoxide production and reducing activity in human platelets.  J Clin Invest. 1977;  59(1) 149-158
  CrossrefPubMedGoogle Scholar
• 15 Gawaz M, Neumann F J, Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy.  Circulation. 1999;  99(1) E1-E11
  PubMedGoogle Scholar
• 16 Bigalke B, Lindemann S, Ehlers R et al.. Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome.  Eur Heart J. 2006;  27(18) 2165-2169
  CrossrefPubMedGoogle Scholar
• 17 Roth D R, Axel D I, Betz E L. In vitro model of the inner parts of a vessel wall with cultured human vascular cells.  Coron Artery Dis. 1993;  4 283-291
  CrossrefPubMedGoogle Scholar
• 18 Axel D I, Brehm B R, Wolburg-Buchholz K, Betz E L, Köveker G, Karsch K R. Induction of cell-rich and lipid-rich plaques in a transfilter coculture system with human vascular cells.  J Vasc Res. 1996;  33(4) 327-339
  CrossrefPubMedGoogle Scholar
• 19 Langer H, May A E, Daub K et al.. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro.  Circ Res. 2006;  98(2) e2-e10
  CrossrefPubMedGoogle Scholar
• 20 Gawaz M, Brand K, Dickfeld T et al.. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.  Atherosclerosis . 2000;  148 75-85
  CrossrefPubMedGoogle Scholar
• 21 Weyrich A, Cipollone F, Mezzetti A et al.. Platelets in atherothrombosis: new and evolving roles.  Curr Pharm Des. 2007;  13 1685-1691
  CrossrefPubMedGoogle Scholar
• 22 Massberg S, Brand K, Grüner S et al.. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.  J Exp Med. 2002;  196(7) 887-896
  CrossrefPubMedGoogle Scholar
• 23 Steinberg D. Low density lipoprotein oxidation and its pathobiological significance.  J Biol Chem. 1997;  272(34) 20963-20966
  CrossrefPubMedGoogle Scholar
• 24 Ammon C, Kreutz M, Rehli M, Krause S W, Andreesen R. Platelets induce monocyte differentiation in serum-free coculture.  J Leukoc Biol. 1998;  63(4) 469-476
  PubMedGoogle Scholar
• 25 Relou I A, Hackeng C M, Akkerman J W, Malle E. Low-density lipoprotein and its effect on human blood platelets.  Cell Mol Life Sci. 2003;  60(5) 961-971
  PubMedGoogle Scholar
• 26 Pedreño J, Hurt-Camejo E, Wiklund O, Badimón L, Masana L. Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling.  Atherosclerosis. 2001;  155(1) 99-112
  CrossrefPubMedGoogle Scholar
• 27 Hartwich J, Dembinska-Kieć A, Gruca A et al.. Regulation of platelet adhesion by oxidized lipoproteins and oxidized phospholipids.  Platelets. 2002;  13(3) 141-151
  CrossrefPubMedGoogle Scholar
• 28 Dardik R, Varon D, Tamarin I et al.. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.  Thromb Haemost. 2000;  83(2) 338-344
  PubMedGoogle Scholar
• 29 Carnevale R, Pignatelli P, Lenti L et al.. LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes.  FASEB J. 2007;  21(3) 927-934
  CrossrefPubMedGoogle Scholar
• 30 Korporaal S J, Gorter G, van Rijn H J, Akkerman J W. Effect of oxidation on the platelet-activating properties of low-density lipoprotein.  Arterioscler Thromb Vasc Biol. 2005;  25(4) 867-872
  CrossrefPubMedGoogle Scholar
• 31 Krötz F, Sohn H Y, Gloe T et al.. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment.  Blood. 2002;  100(3) 917-924
  CrossrefPubMedGoogle Scholar
• 32 Pignatelli P, Sanguigni V, Lenti L et al.. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.  J Thromb Haemost. 2007;  5 1170-1178
  CrossrefPubMedGoogle Scholar
• 33 Puccetti L, Pasqui A L, Pastorelli M et al.. Platelet hyperactivity after statin treatment discontinuation.  Thromb Haemost. 2003;  90(3) 476-482
  PubMedGoogle Scholar
• 34 Aviram M, Fuhrman B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.  Mol Cell Biochem. 1998;  188(1-2) 149-159
  CrossrefPubMedGoogle Scholar
• 35 Martinovic I, Abegunewardene N, Seul M et al.. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.  Circ J. 2005;  69(12) 1484-1489
  CrossrefPubMedGoogle Scholar
• 36 Tabata T, Mine S, Kawahara C, Okada Y, Tanaka Y. Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells.  Biochem Biophys Res Commun. 2003;  305(2) 380-385
  CrossrefPubMedGoogle Scholar
• 37 Stellos K, Langer H, Daub K et al.. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells.  Circulation. 2008;  117(2) 206-215
  CrossrefPubMedGoogle Scholar
• 38 Ma F X, Zhou B, Chen Z et al.. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase.  J Lipid Res. 2006;  47(6) 1227-1237
  CrossrefPubMedGoogle Scholar
• 39 Vainio S, Ikonen E. Macrophage cholesterol transport: a critical player in foam cell formation.  Ann Med. 2003;  35(3) 146-155
  CrossrefPubMedGoogle Scholar
• 40 Keiper T, Al-Fakhri N, Chavakis E et al.. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.  FASEB J. 2005;  19(14) 2078-2080
  PubMedGoogle Scholar
• 41 Ostermann G, Fraemohs L, Baltus T et al.. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A.  Arterioscler Thromb Vasc Biol. 2005;  25(4) 729-735
  CrossrefPubMedGoogle Scholar
• 42 Chen T, Febbraio M, Li W, Silverstein R L. A specific CD36 dependent signaling pathway is required for platelet activation by oxidized low-density lipopiotein.  Circ Res. 2008;  102(12) 1512-1519
  CrossrefPubMedGoogle Scholar

Stephan LindemannM.D. 

Medizinische Klinik, Abt. III, Kardiologie und Kreislauferkrankungen

Eberhard-Karls-Universität Tübingen, Otfried-Müller-Str.10, D-72076 Tübingen, Germany

Email: Stephan.lindemann@med.uni-tuebingen.de